JM-010
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for JM-010, covering 2016-01-13 to 2024-06-17. Get the full timeline:
Most recent: Clinical Trial Update: Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components [Phase 2]